BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16608026)

  • 21. [Retrospective analysis of tegafur/uracil (UFT) plus oral leucovorin (LV) regimen in patients with advanced colorectal cancer].
    Sato Y; Inaba Y; Yamaura H; Shimamoto H; Nishiofuku H; Oyama T; Kanemitsu Y; Sawaki A; Arai Y; Muro K
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):887-90. PubMed ID: 16835473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concomitant administration of uracil-tegafur and leucovorin during adjuvant radiotherapy for locally advanced rectal cancer.
    Atasoy BM; Abacioglu U; Dane F; Ozgen Z; Yumuk PF; Ozden S; Akgun Z; Mayadagli A; Basaran G; Turhal S; Sengoz M
    J BUON; 2007; 12(2):203-8. PubMed ID: 17600873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early phase II study of uracil-tegafur plus doxorubicin in patients with unresectable advanced biliary tract cancer.
    Furuse J; Okusaka T; Funakoshi A; Yamao K; Nagase M; Ishii H; Nakachi K; Ueno H; Ikeda M; Morizane C; Horikawa Y; Mizuno N
    Jpn J Clin Oncol; 2006 Sep; 36(9):552-6. PubMed ID: 16887837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase II trial of modified FOLFOX as first-line chemotherapy in advanced colorectal cancer.
    Xiong JP; Zhang L; Zhong LX; Qiu F; Xu J; Tao QS; Xiang XJ; Yu F; Tang XM
    Anticancer Drugs; 2007 Oct; 18(9):1103-7. PubMed ID: 17704661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II study of uracil-tegafur plus cisplatin in patients with previously untreated advanced non-small cell lung cancer.
    Takayama K; Kawasaki M; Ninomiya K; Motohiro A; Fujita M; Watanabe K; Kajiki A; Iwami F; Miyazaki N; Izumi M; Hara N; Nakanishi Y;
    Respirology; 2008 Jan; 13(1):103-7. PubMed ID: 18197918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Combined chemotherapy with oral leucovorin (LV) + tegafur/uracil (UFT) and hepatic arterial infusion (HAI) therapy for liver metastasis of colorectal cancer].
    Hasegawa S; Matsumoto S; Kawashima K; Fujii H; Hatano E; Satoh S; Ikai I; Shimahara Y
    Gan To Kagaku Ryoho; 2005 Jul; 32(7):1045-9. PubMed ID: 16044971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multiple-center phase II study of biweekly oxaliplatin and tegafur-uracil/leucovorin for chemonaive patients with advanced gastric cancer.
    Chen JS; Rau KM; Chen YY; Huang JS; Yang TS; Lin YC; Liau CT; Lee KD; Su YC; Kao RH
    Cancer Chemother Pharmacol; 2009 Apr; 63(5):819-25. PubMed ID: 18663448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II trial of oral uracil/tegafur plus leucovorin in patients with hormone-refractory prostate carcinoma.
    Bhandari MS; Pienta KJ; Fardig J; Olson K; Smith DC
    Cancer; 2006 Apr; 106(8):1715-21. PubMed ID: 16534795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. UFT/leucovorin and mitomycin C as salvage treatment in patients with advanced colorectal cancer - a retrospective analysis.
    Vormittag L; Kornek GV; Gruhsmann B; Lenauer A; Föger A; Depisch D; Lang F; Scheithauer W
    Anticancer Drugs; 2007 Jul; 18(6):709-12. PubMed ID: 17762401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. UFT plus or minus calcium folinate for metastatic colorectal cancer in older patients.
    Díáz-Rubio E; Sastre J; Abad A; Navarro M; Aranda E; Carrato A; Gallén M; Marcuello E; Rifá J; Massuti T; Cervantes A; Antón A; Fernández Martos C
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):35-40. PubMed ID: 10442357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A retrospective study of bifractionated CPT-11 with LF5FU infusion (FOLFIRI-3) in colorectal cancer patients pretreated with oxaliplatin and CPT-11 containing chemotherapies.
    Viel E; Demarchi MF; Chaigneau L; Nguyen T; Legat C; Stein U; Thiery-Vuillemin A; Limat S; Pivot X; Borg C
    Am J Clin Oncol; 2008 Feb; 31(1):89-94. PubMed ID: 18376234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pre-operative chemoradiotherapy with UFT and Leucovorin in patients with advanced rectal cancer: a phase II study.
    Giralt J; Tabernero J; Navalpotro B; Capdevila J; Espin E; Casado E; Mañes A; Landolfi S; Sanchez-Garcia JL; de Torres I; Armengol M
    Radiother Oncol; 2008 Dec; 89(3):263-9. PubMed ID: 18768230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II study of cisplatin, epirubicin, UFT, and leucovorin (PELUF) as first-line chemotherapy in metastatic gastric cancer.
    Idelevich E; Karminsky N; Dinerman M; Katsenelson RL; Zvi NB; Baruch NB; Biran H; Man S; Shani A
    Acta Oncol; 2007; 46(3):324-9. PubMed ID: 17450467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effective treatment with oral administration of UFT and leucovorin (Uzel) in a patient with liver metastasis and peritoneal dissemination from cecal cancer].
    Mimatsu K; Kawasaki A; Aramaki O; Kuboi Y; Amano S; Oida T
    Gan To Kagaku Ryoho; 2008 Apr; 35(4):653-5. PubMed ID: 18408438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of right-sided tumors with high thymidine phosphorylase gene expression levels and the response to oral uracil and tegafur/leucovorin chemotherapy among patients with colorectal cancer.
    Sadahiro S; Suzuki T; Tanaka A; Okada K; Nagase H; Uchida J
    Cancer Chemother Pharmacol; 2012 Aug; 70(2):285-91. PubMed ID: 22752215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy of epirubicin, cisplatin, uracil/tegafur, and leucovorin in patients with advanced biliary tract carcinoma.
    Park KH; Choi IK; Kim SJ; Oh SC; Seo JH; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS
    Cancer; 2005 Jun; 103(11):2338-43. PubMed ID: 15825161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
    Furuse J; Okusaka T; Ohkawa S; Nagase M; Funakoshi A; Boku N; Yamao K; Yamaguchi T; Sato T
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):113-20. PubMed ID: 19404641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uracil-Tegafur and Oral Leucovorin Combined With Bevacizumab in Elderly Patients (Aged ≥ 75 Years) With Metastatic Colorectal Cancer: A Multicenter, Phase II Trial (Joint Study of Bevacizumab, Oral Leucovorin, and Uracil-Tegafur in Elderly Patients [J-BLUE] Study).
    Nishina T; Moriwaki T; Shimada M; Higashijima J; Sakai Y; Masuishi T; Ozeki M; Amagai K; Negoro Y; Indo S; Denda T; Sato M; Yamamoto Y; Nakajima G; Mizuta M; Takahashi I; Hiroshima Y; Ishida H; Maeba T; Hyodo I
    Clin Colorectal Cancer; 2016 Sep; 15(3):236-42. PubMed ID: 26778644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Two metastatic colonic cancer patients successfully treated by combination therapy of tegafur/uracil (UFT) and oral Leucovorin].
    Ina K; Kataoka T; Ohkita T; Nagao S; Ito A; Inagaki J; Kato H; Ando T; Niwa Y; Goto H
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1469-71. PubMed ID: 17033240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Preoperative chemotherapy for advanced colorectal carcinomas--comparison of histological effect between UFT + leucovorin tablet and UFT alone].
    Maruyama M; Kudo T; Kuwabara H; Yoshida T; Sugano N; Ebuchi M
    Gan To Kagaku Ryoho; 1998 Apr; 25(5):691-6. PubMed ID: 9571966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.